NPAT up 26% on 17% revenue growth, but OCF swung NZD49.6m negative

What changed

Turners Automotive Group (TRA) delivered HY22 revenue from continuing operations of NZD$164.6m, up 17% on HY21's $141.0m. PBT grew 24% to $23.2m (from $18.7m) and NPAT from continuing operations rose 26% to $16.9m (from $13.4m). Total net profit, which includes a contribution not fully broken out in the supplied extraction, reached $18.4m, up 37%. The interim dividend held at NZD$0.05 per share, consistent with the prior half.

The cash picture was the stark reversal. Operating cash flow came in at negative $22.7m against a positive $27.0m in HY21 — a swing of nearly $49.6m. Capex more than doubled to $8.5m from $3.8m. Gross borrowings expanded from $314.4m to $374.3m, a $59.9m increase, implying net debt of approximately $360m against cash of $14.2m.

The full-year FY21 seasonality pattern is relevant here: HY21 captured 62.8% of full-year NPAT and 55.5% of full-year revenue, meaning the second half historically has been materially softer on earnings.

What matters

The operating cash flow reversal is the central concern. A nearly $49.6m swing from positive to negative OCF while P&L profits improved 26% points to a significant working capital or balance sheet movement within the period — most likely growth in the consumer finance loan book, which in automotive retail and finance tends to flow through operating cash rather than investing cash. If receivable growth in the finance book is driving the OCF deterioration, it is not necessarily alarming, but it does mean the business is funding growth through borrowings rather than retained cash generation. The $59.9m lift in gross borrowings broadly corroborates this interpretation.

Earnings quality on the P&L is supported by strong revenue growth. A 17% revenue gain driving 24% PBT growth implies some operating leverage or improving credit margin. The company's own commentary in the FY21 anchor period referenced a strategy of attracting higher-quality borrowers with lower margins offset by lower impairments — if that dynamic persisted into HY22, reported margins may be understating underlying credit risk reduction. Gross margin detail is not disclosed, so this cannot be confirmed.

The gap between continuing operations NPAT ($16.9m) and total net profit ($18.4m) implies a $1.5m post-tax contribution from non-continuing or non-recurring items that is not decomposed in the available disclosures. This is a modest gap but worth tracking.

Expectations

No formal earnings targets were disclosed for HY22 or FY22. Using the HY21/FY21 shape as a guide, HY22 was again a first-half weighted period (HY21 was 62.8% of full-year NPAT), so the implied second-half NPAT run rate from FY21 precedent would be roughly $10m. If the same seasonal pattern holds in FY22, annualised NPAT from continuing operations would be approximately $26–27m — which is broadly consistent with HY22's $16.9m representing around 63% of an estimated full year.

Annualised HY22 revenue of approximately $329m sits about 11% above the FY21 anchor of $296.5m, which is plausible if the automotive retail market remained buoyant. However, the OCF profile complicates any simple extrapolation: FY21 OCF was only $10.9m for the full year despite the second half generating $33.6m, meaning HY21's $27m positive OCF was largely reversed in HY21's second half. Whether a similar reversal occurs in HY22's second half, or whether the HY22 cash outflow deepens, depends on loan book growth trajectory and inventory management — neither of which is forward-guided.

Quality of result

The P&L result looks relatively durable in terms of top-line growth, which is broad-based across what appears to be automotive retail volumes and finance book origination. The 24% PBT growth on 17% revenue growth is a credible result for this segment if vehicle margins held and credit costs remained contained.

The cash result is a different matter. Negative $22.7m OCF against $16.9m NPAT implies free cash flow (pre-lease) of approximately negative $31.2m — meaning the dividend is not covered by cash generation. The interim dividend implies a payout of roughly $3.5m (at $0.05 per share across approximately 70m shares implied by the payout ratio analysis), which is entirely funded by borrowings in this half. That is not unusual for a finance company where book growth requires upfront capital, but it does mean the sustainability of the dividend depends on the quality and yield of the receivables being originated, not on near-term cash generation.

Inventory days and receivable days on the trade book are essentially unchanged, which is a modest positive for retail discipline — no evidence of markdown pressure or slow-moving stock build on the used-car side.

Unresolved

• The driver of the $49.6m OCF swing is not decomposed in the available disclosures. Whether it is consumer receivables growth, floor-plan inventory financing, or other working capital requires the full cash flow statement breakdown.
• Gross margin and credit impairment trends are not available in the normalized extraction, making it impossible to assess whether the earnings quality improvement cited in FY21 strategy (better borrower quality, lower impairments) carried into HY22.
• The $1.5m gap between continuing NPAT and total net profit is unexplained — the nature of the contributing item (discontinued operation, asset sale, or other) is not identified in the supply.
• Leverage trajectory is the key watch item: borrowings have grown $59.9m in six months to $374.3m, and the full-year cash generation profile will determine whether this is self-funding book growth or structural leverage creep.
• Second-half seasonality risk is real — FY21 precedent shows the second half contributed only $10m of full-year NPAT, so any market softening in the automotive or credit cycle would have an outsized HY22 second-half effect.

This briefing cannot assess whether HY22's loan book growth is being originated at acceptable credit quality, as impairment and arrears data were not included in the extraction.

Key metrics

Analytical metrics

---

This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.